Attached files

file filename
S-1 - REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - PREMIER BIOMEDICAL INCv225682_s1.htm
EX-3.3 - CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK - PREMIER BIOMEDICAL INCv225682_ex3-3.htm
EX-3.1 - ARTICLES OF INCORPORATION OF PREMIER BIOMEDICAL, INC. - PREMIER BIOMEDICAL INCv225682_ex3-1.htm
EX-3.2 - BYLAWS OF PREMIER BIOMEDICAL, INC. - PREMIER BIOMEDICAL INCv225682_ex3-2.htm
EX-10.3 - PREFERRED STOCK PURCHASE WARRANT ISSUED TO MITCHELL FELDER - PREMIER BIOMEDICAL INCv225682_ex10-3.htm
EX-10.2 - LICENSE AGREEMENT DATED MAY 12, 2010 WITH MARV ENTERPRISES, LLC. - PREMIER BIOMEDICAL INCv225682_ex10-2.htm
EX-10.6 - COMMON STOCK PURCHASE WARRANT ISSUED TO WILLIAM A. HARTMAN - PREMIER BIOMEDICAL INCv225682_ex10-6.htm
EX-10.1 - LICENSE AGREEMENT DATED MAY 12, 2010 WITH ALTMAN ENTERPRISES, INC. - PREMIER BIOMEDICAL INCv225682_ex10-1.htm
EX-10.4 - PREFERRED STOCK PURCHASE WARRANT ISSUED TO WILLIAM A. HARTMAN - PREMIER BIOMEDICAL INCv225682_ex10-4.htm
EX-10.8 - PROMISSORY NOTE ISSUED TO WILLIAM A. HARTMAN DATED DECEMBER 31, 2010 - PREMIER BIOMEDICAL INCv225682_ex10-8.htm
EX-10.9 - PROMISSORY NOTE ISSUED TO MITCHELL FELDER DATED DECEMBER 31, 2010 - PREMIER BIOMEDICAL INCv225682_ex10-9.htm
EX-10.5 - COMMON STOCK PURCHASE WARRANT ISSUED TO MITCHELL FELDER - PREMIER BIOMEDICAL INCv225682_ex10-5.htm
EX-10.7 - COMMON STOCK PURCHASE WARRANT ISSUED TO THE LEBRECHT GROUP, APLC - PREMIER BIOMEDICAL INCv225682_ex10-7.htm
EX-10.12 - FORM OF WARRANT SOLD IN PRIVATE PLACEMENT - PREMIER BIOMEDICAL INCv225682_ex10-12.htm
EX-10.11 - PROMISSORY NOTE ISSUED TO MITCHELL FELDER DATED MARCH 31, 2011 - PREMIER BIOMEDICAL INCv225682_ex10-11.htm
EX-10.10 - PROMISSORY NOTE ISSUED TO WILLIAM A. HARTMAN DATED MARCH 31, 2011 - PREMIER BIOMEDICAL INCv225682_ex10-10.htm
 
Exhibit 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 Premier Biomedical, Inc.
 
 We consent to the use of our report dated June 13, 2011 with respect to the financial statements of Premier Biomedical, Inc. as of December 31, 2010, and the related statements of operations, stockholders' equity (deficit) and cash flows for the period from inception on May 10, 2010, through December 31, 2010, and to the reference to our firm under the caption “Experts”, included in the Registration Statement on Form S-1 filed by Premier Biomedical, Inc. on June 14, 2011.
 
  /s/ M&K CPAS, PLLC
 
 Houston, Texas
 
 June 14, 2011